The results of this study were recently presented by Dr Alexander Chang, Associate Professor, Department of Population Health Sciences, Geisinger at the American Heart Association’s Hypertension Scientific Sessions in Chicago.

Introduction

Chronic kidney disease (CKD) poses a significant risk to millions of American adults, with one in three individuals at-risk of the condition. Despite the importance of regular urine albumin-to-creatinine ratio testing (uACR), many people fail to complete this crucial test.

However, with the widespread accessibility of smartphones among 90% of American adults, solutions like Minuteful Kidney represent new opportunities. Leveraging smartphone technology, at-home digital health testing has the potential to transform the way providers, payers, and patients address health challenges like CKD. Using the Minuteful Kidney solution can help eliminate barriers to health, reduce health inequities and drive patients back into care.

Results

The study revealed:

• Minuteful Kidney dramatically improved uACR screening rates compared to the control group
• Satisfaction was high among individuals in the Minuteful Kidney home testing group (53+ NPS, 94% rated the test as easy or very easy to complete, 88% stated preference for at home testing)
• Majority of patients communicated with providers about results with further testing
• The increase in uACR testing is consistent across demographic subgroups

Conclusion

Ultimately, this promising data shows that a population health approach using smartphone-enabled home uACR testing is effective in increasing screening and follow-up care among individuals with type 2 diabetes or hypertension. By identifying CKD earlier and ensuring timely intervention, this approach will contribute to better disease management and improved long-term outcomes. 

A copy of the poster is available below.